Break–apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements. European Journal of Endocrinology
(2015) Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses. PLoS ONE 10(4): e0121815.
Sara Mariani1, Cristiana Di Bello2,4, Lisa Bonello3,4, Fabrizio Tondat3, Donatella Pacchioni2, Luca Molinaro2, Antonella Barreca1, Luigia Macrì2, Luigi Chiusa2, Paola Francia di Celle2, Paola Cassoni1, Anna Sapino1 1Department of Medical Sciences; University of Torino, Torino, Italy 2Azienda Ospedaliera Universitaria Città della Salute e della Scienza; Presidio Ospedaliero Molinette of Torino, Torino, Italy 3Department of Molecular […]
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. Modern Pathology
Daniela Massi1, Lisa Simi2, Elisa Sensi3, Gianna Baroni1, Gongda Xue4, Cristian Scatena1, Adele Caldarella5, Pamela Pinzani2, Gabriella Fontanini3, Alessandra Carobbio6, Carmelo Urso7 and Mario Mandalà8 1Division of Pathological Anatomy, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy 2Clinical Biochemistry Unit, Department of Biomedical, Experimental and Clinical Sciences, University of Florence, Florence, Italy […]
MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology
Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family. Carcinogenesis
Giulia Cini1, Ileana Carnevali2, Michele Quaia1, Anna Maria Chiaravalli2, Paola Sala3, Elisa Giacomini1, Roberta Maestro1, Maria Grazia Tibiletti2, Alessandra Viel1 1Experimental Oncology 1, CRO Aviano, National Cancer Institute, 33081 Aviano (PN), Italy 2Pathology Unit, Ospedale di Circolo e Fondazione Macchi Polo Universitario, 21100 Varese, Italy 3Hereditary Digestive Tract Tumors Unit, Foundation IRCCS-INT, 20133 Milan, Italy […]
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology Letters
Authors: Elisa Chiadini, Emanuela Scarpi, Alessandro Passardi, Daniele Calistri, Martina Valgiusti, Luca Saragoni, Wainer Zoli, Dino Amadori, Paola Ulivi Affiliations: Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) […]
Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncology
Luisa Foltran1,2, Giovanna De Maglio3, Nicoletta Pella1, Paola Ermacora1, Giuseppe Aprile1, Elena Masiero3, Mariella Giovannoni1, Emiliana Iaiza1, Giovanni Gerardo Cardellino1, Stefania Eufemia Lutrino1, Micol Mazzer1,4, Manuela Giangreco5, Federica Edith Pisa5, Stefano Pizzolitto3 & Gianpiero Fasola1 1Department of Oncology, University Hospital ‘S Maria della Misericordia’, Piazzale S Maria della Misericordia 15, Udine, Italy 2Department of Oncology, […]
A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Journal of the European Academy of Dermatology and Venereology
Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocrine-Related Cancer
P2X7 mRNA expression in non?small cell lung cancer: MicroRNA regulation and prognostic value. Oncology Letters
Authors: Laura Boldrini, Mirella Giordano, Greta Alì, Franca Melfi, Gaetano Romano, Marco Lucchi, Gabriella Fontanini Affiliations: Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa 56126, Italy, Unit of Pathological Anatomy III, University Hospital of Pisa, Pisa 56126, Italy, Unit of Thoracic Surgery, University Hospital of Pisa, Pisa 56126, Italy. Abstract […]